The Pennant Group, Inc. (PNTG) vs Rapport Therapeutics, Inc. Common Stock (RAPP)

A side-by-side comparison of The Pennant Group, Inc. and Rapport Therapeutics, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
The Pennant Group, Inc. logo
PNTG
The Pennant Group, Inc.
$1.41B
$40.54HealthcareDelayed quote: Oct 6, 2026, 1:40 PM EDT
Rapport Therapeutics, Inc. Common Stock logo
RAPP
Rapport Therapeutics, Inc. Common Stock
$1.46B
$30.59HealthcareDelayed quote: Oct 6, 2026, 1:39 PM EDT

Total return — PNTG vs RAPP

growth of $100 · dividends reinvested · last 2y
PNTG +77.2% (+33.1%/yr)RAPP +54.8% (+24.4%/yr)PNTG compounded faster over this window
50100150200250Start $10020252026$177$155
PNTG RAPP

PNTG vs RAPP: by the numbers

  • •RAPP is the larger company ($1.46B vs $1.41B market cap).
  • •PNTG is profitable (2.93% net margin) while RAPP runs a net loss (-685.80%).

Metrics side by side

Valuation

MetricPNTGRAPP
P/E ratio45.05N/A
Forward P/E29.05N/A
PEG ratio4.47N/A
P/S ratio1.2873.15
P/B ratio3.923.46
EV / EBITDA25.62N/A
FCF yield1.84%N/A

Profitability

MetricPNTGRAPP
Gross margin14.79%0.00%
Operating margin5.77%0.00%
Net margin2.93%-685.80%
ROE9.00%-32.43%
ROIC5.22%-35.66%

Growth (annualized)

MetricPNTGRAPP
Revenue CAGR (5Y)21.14%N/A
EPS CAGR (5Y)8.96%N/A
Total return CAGR (5Y)8.88%N/A

Frequently asked

Is PNTG or RAPP more profitable?
PNTG runs the higher net margin — PNTG at 2.93% versus RAPP at -685.80%.

Go deeper

Full PNTG analysisFull RAPP analysisInteractive comparison tool

Dig into the metrics

Pennant P/E ratioPennant ROERapport Therapeutics, Inc. Common Stock ROEPennant operating marginRapport Therapeutics, Inc. Common Stock operating marginPennant revenue growthRapport Therapeutics, Inc. Common Stock revenue growthPennant free cash flowRapport Therapeutics, Inc. Common Stock free cash flow

Pennant & Rapport Therapeutics, Inc. Common Stock appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.